Figure 2From: Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathwayAssessment of cardiac function in infarcted mouse hearts transplanted with chorionic plate mesenchymal stem cells (cp-MSCs) or placebo. Echocardiography was performed before (corresponding to day -22 of treatment) and 20 days after myocardial infarction (corresponding to day -1 of treatment) to obtain baseline values in mice receiving cp-MSCs (squares) or placebo (triangles). Analysis of (A) ejection fraction, (B) end-diastolic volume, and (C) end-systolic volume was performed every 7 days after each cell or placebo injection. Day 7 corresponds to 7 days after the first injection, day 15 corresponds to 7 days after the second injection, and day 23 corresponds to 7 days after the third injection. Animals were followed up to 39 days after the first injection. *P <0.05 and **P <0.01 when comparing cp-MSC with placebo group at each time point. Sham-operated mice (circles), which did not undergo left anterior descending coronary artery occlusion, are shown as controls to indicate normal values for each parameter.Back to article page